A subset of neutrophils as a predictive biomarker for immunotherapy response in patients with non-small-cell lung cancer and melanoma

被引：0
|
作者：
Shaked, Yuval
Benguigui, Madeleine
Halaban, Ruth
Bacchiocchi, Antonella
Kamer, Iris
Bar, Jair
Lotem, Michal
Shen-Orr, Shai
Sznol, Mario
Cooper, Tim J.
机构：
[1] Technion, Haifa, Israel
[2] Technion Israel Inst Technol, Haifa, Israel
[3] Yale Sch Med, New Haven, CT USA
[4] Yale Univ, Sch Med, New Haven, CT USA
[5] Inst Oncol, Sheba Med Ctr, Ramat Gan, Israel
[6] Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel
[7] Yale Univ, Yale New Haven Hosp, Smilow Canc Hosp, Yale Canc Ctr,Sch Med, New Haven, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
基金：
欧洲研究理事会;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2557
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Predictive factors associated with gefitinib response in patients with advanced non-small-cell lung cancer (NSCLC)
    Chen, Lian
    Chen, Rui
    Zhu, Zhe
    Zhang, Yichen
    Wen, Zhengwei
    Li, Yun
    Li, Xiaoming
    Luo, Yuwen
    Ma, Liyu
    Lin, Shuguang
    Chen, Xin
    CHINESE JOURNAL OF CANCER RESEARCH, 2014, 26 (04) : 466 - 470
  • [42] Blood Predictive Biomarkers for Patients With Non-small-cell Lung Cancer Associated With Clinical Response to Nivolumab
    Teresa Agullo-Ortuno, M.
    Gomez-Martin, Oscar
    Ponce, Santiago
    Iglesias, Lara
    Ojeda, Laura
    Ferrer, Irene
    Garcia-Ruiz, Inmaculada
    Paz-Ares, Luis
    Pardo-Marques, Virginia
    CLINICAL LUNG CANCER, 2020, 21 (01) : 75 - 85
  • [43] Nuclear survivin as a biomarker for non-small-cell lung cancer
    Lu, B
    Gonzalez, A
    Massion, PP
    Shyr, Y
    Shaktour, B
    Carbone, DP
    Hallahan, DE
    BRITISH JOURNAL OF CANCER, 2004, 91 (03) : 537 - 540
  • [44] Predictive factors associated with gefitinib response in patients with advanced non-small-cell lung cancer(NSCLC)
    Lian Chen
    Rui Chen
    Zhe Zhu
    Yichen Zhang
    Zhengwei Wen
    Yun Li
    Xiaoming Li
    Yuwen Luo
    Liyu Ma
    Shuguang Lin
    Xin Chen
    Chinese Journal of Cancer Research, 2014, 26 (04) : 466 - 470
  • [45] Identification of CXCL5 expression as a predictive biomarker associated with response and prognosis of immunotherapy in patients with non-small cell lung cancer
    Deng, Jie
    Ma, Xuejiao
    Ni, Yang
    Li, Xiaomin
    Xi, Wenjing
    Tian, Minqi
    Zhang, Xing
    Xiang, Manyu
    Deng, Wanglong
    Song, Chao
    Wu, Hao
    CANCER MEDICINE, 2022, 11 (08): : 1787 - 1795
  • [46] Predictive biomarkers of response for immune checkpoint inhibitors in non-small-cell lung cancer
    Prelaj, Arsela
    Tay, Rebecca
    Ferrara, Roberto
    Chaput, Nathalie
    Besse, Benjamin
    Califano, Raffaele
    EUROPEAN JOURNAL OF CANCER, 2019, 106 : 144 - 159
  • [47] Treatment patterns in patients with metastatic non-small-cell lung cancer in the era of immunotherapy
    Stenehjem, David
    Lubinga, Solomon
    Betts, Keith A.
    Tang, Wenxi
    Jenkins, Mads
    Yuan, Yong
    Hartman, John
    Rao, Sumati
    Lam, Jenny
    Waterhouse, David
    FUTURE ONCOLOGY, 2021, 17 (22) : 2940 - 2949
  • [48] Salvage Chemotherapy After Immunotherapy Failure in Non-Small-Cell Lung Cancer Patients
    Randon, G.
    Galli, G.
    De Toma, A.
    Pagani, F.
    Trevisan, B.
    Signorelli, D.
    Proto, C.
    Prelaj, A.
    Ferrara, R.
    Ganzinelli, M.
    Pallavicini, L.
    Di Mauro, R.
    Zilembo, N.
    De Braud, F.
    Garassino, M.
    Lo Russo, G.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S416 - S416
  • [49] Immunotherapy in Non-Small-Cell Lung Cancer Patients with Driver Alterations: A New Strategy?
    Krzyzanowska, Natalia
    Krawczyk, Pawel
    Wojas-Krawczyk, Kamila
    Kucharczyk, Tomasz
    Milanowski, Janusz
    CELLS, 2022, 11 (20)
  • [50] Rate of cancer progression as a predictive marker of efficacy of immunotherapy; an analysis in metastatic non-small-cell lung cancer
    Prasanna, Thiru
    Arasaratnam, Mal
    Boyer, Michael
    McNeil, Catriona
    Barnet, Megan B.
    Asher, Rebecca
    Hui, Rina
    Nagrial, Adnan
    Kao, Steven
    IMMUNOTHERAPY, 2019, 11 (08) : 657 - 665
12345